Scale-up Readiness Oppenheimer Enterprises is transitioning from early analytical protocol development to scale-up, creating a potential need for process development, pilot-scale equipment, and tech-transfer support to accelerate the second phase of work.

Analytical Solutions The focus on rapid, high-resolution electrokinetic separations for clinically significant serum proteins signals opportunities to provide analytical instrumentation, method development and validation services, and consumables tailored to protein separations.

Avidity Collaboration Their emphasis on enhanced antibody avidity procedures opens doors for partnerships in affinity maturation, binding assays, and contract research to optimize antibody performance for clinical or diagnostic applications.

Outsourced R&D With a very small internal team, the company could benefit from CRO/CMO partnerships for research, process development, and scale-up activities, enabling faster progress through outsourced help and faster tech transfer.

Digital Marketing The existing tech stack and online presence suggest potential for collaboration on digital marketing, analytics optimization, and website strategy to attract collaborations, customers, or grant opportunities.